Founder
CurrentCurrently we are in initial phase developing strong network connections and we are striving to develop partnerships with both MAPS, Dell School of Medicine, Center for Psychedelic Research and other nonprofit organization actively involved in clinical research aiming to bring more psychedelic treatment modalities into mainstream acceptance.“Current breakthroughs in mental health-focused psychedelic research across the globehave led the medical community toreevaluate these previously stigmatizedparty drugs. Dell Medical School's recentlyannounced Center for Psychedelic Researchand Therapy will establish the city as a majorhub for both tech and cutting-edge researcharound the drugs' effects in relation toconditions like depression, anxiety, and PTSD.And as the growing mental health crisisreaches critical mass, many see this potentialinformation as pieces of a puzzle that can'tarrive fast enough.Psilocybin and MDMA, which are both ontrack to receive FDA approval in the next fewyears, could be among these breakthroughs.Part of the perceived benefits of these once-fringe cures lies in the idea that they induceneuroplasticity, or the brain's ability to rewireitself. which could help those with mentalillnesses break free of negative thought oraction patterns. "It's akin to warming clay,"explains Greg Fonzo, co-lead of Dell Med'snew center. “The brain is kind of stuck in thisunhelpful shape, so to speak. If we warm theclay, that should allow it to become moremoldable.”" (Source: Austin Monthly)